Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Topical
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
59
PharmaCompass offers a list of Gadolinium Ethoxybenzyl Dtpa API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gadolinium Ethoxybenzyl Dtpa manufacturer or Gadolinium Ethoxybenzyl Dtpa supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gadolinium Ethoxybenzyl Dtpa manufacturer or Gadolinium Ethoxybenzyl Dtpa supplier.
PharmaCompass also assists you with knowing the Gadolinium Ethoxybenzyl Dtpa API Price utilized in the formulation of products. Gadolinium Ethoxybenzyl Dtpa API Price is not always fixed or binding as the Gadolinium Ethoxybenzyl Dtpa Price is obtained through a variety of data sources. The Gadolinium Ethoxybenzyl Dtpa Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A eovist manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of eovist, including repackagers and relabelers. The FDA regulates eovist manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. eovist API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of eovist manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A eovist supplier is an individual or a company that provides eovist active pharmaceutical ingredient (API) or eovist finished formulations upon request. The eovist suppliers may include eovist API manufacturers, exporters, distributors and traders.
click here to find a list of eovist suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A eovist DMF (Drug Master File) is a document detailing the whole manufacturing process of eovist active pharmaceutical ingredient (API) in detail. Different forms of eovist DMFs exist exist since differing nations have different regulations, such as eovist USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A eovist DMF submitted to regulatory agencies in the US is known as a USDMF. eovist USDMF includes data on eovist's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The eovist USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of eovist suppliers with USDMF on PharmaCompass.
A eovist written confirmation (eovist WC) is an official document issued by a regulatory agency to a eovist manufacturer, verifying that the manufacturing facility of a eovist active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting eovist APIs or eovist finished pharmaceutical products to another nation, regulatory agencies frequently require a eovist WC (written confirmation) as part of the regulatory process.
click here to find a list of eovist suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing eovist as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for eovist API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture eovist as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain eovist and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a eovist NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of eovist suppliers with NDC on PharmaCompass.
eovist Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of eovist GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right eovist GMP manufacturer or eovist GMP API supplier for your needs.
A eovist CoA (Certificate of Analysis) is a formal document that attests to eovist's compliance with eovist specifications and serves as a tool for batch-level quality control.
eovist CoA mostly includes findings from lab analyses of a specific batch. For each eovist CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
eovist may be tested according to a variety of international standards, such as European Pharmacopoeia (eovist EP), eovist JP (Japanese Pharmacopeia) and the US Pharmacopoeia (eovist USP).
